Chloroambucil - CAS 305-03-3
Catalog number: 305-03-3
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H19Cl2NO2
Molecular Weight:
304.21
COA:
Inquire
Targets:
Others
Description:
Chlorambucil (marketed as Leukeran by GlaxoSmithKline) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia. It is a nitrogen mustard alkylating agent and can be given orally. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Chlorambucil
MSDS:
Inquire
1.Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting.
Bachow SH1, Lamanna N2,3. Curr Hematol Malig Rep. 2016 Feb;11(1):61-70. doi: 10.1007/s11899-016-0298-1.
Chronic lymphocytic leukemia (CLL) is a disease of marked clinical heterogeneity, and while some patients have a normal life expectancy, others develop rapidly progressive disease shortly after diagnosis. The current standard for upfront treatment of CLL is chemoimmunotherapy for younger fit patients, FCR (fludarabine, cyclophosphamide, and rituximab) being the prototype. For older patients, BR (bendamustine and rituximab) exhibits excellent activity with decreased toxicity. For the frailest patients, CD20 monoclonal antibodies with or without chlorambucil have proven to be efficacious. The novel oral kinase inhibitors ibrutinib and idelalisib are FDA-approved in the relapsed/refractory setting, and ibrutinib is approved upfront for those with del(17p). These drugs have produced long-term durable responses in the relapsed/refractory setting, and studies are underway using these as single agent upfront or in combination with both chemotherapy and monoclonal antibodies.
2.Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab.
Dawson K1, Moran M2, Guindon K1, Wan H3. Clin J Oncol Nurs. 2016 Apr 1;20(2):E41-8. doi: 10.1188/16.CJON.E41-E48.
BACKGROUND: In patients with previously untreated chronic lymphocytic leukemia (CLL) and comorbidities, treatment with the glycoengineered, type II anti-CD20 monoclonal antibody obinutuzumab (Gazyva®) (GA101) plus chlorambucil (Leukeran®) was associated with superior outcomes to rituximab (Rituxan®) plus chlorambucil, with a similar safety profile. However, a higher occurrence of infusion-related reactions (IRRs) was reported with obinutuzumab. These reactions typically require additional management.
3.Cost-Effectiveness of First-Line Chronic Lymphocytic Leukemia Treatments When Full-Dose Fludarabine Is Unsuitable.
Soini E1, Hautala A2, Poikonen E3, Becker U4, Kyttälä M2, Martikainen J5. Clin Ther. 2016 Mar 9. pii: S0149-2918(16)30056-X. doi: 10.1016/j.clinthera.2016.02.005. [Epub ahead of print]
PURPOSE: The cost-effectiveness of first-line chronic lymphocytic leukemia treatments was assessed among patients unsuitable for full doses of fludarabine.
4.Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.
Vidal L1,2, Gurion R1,2, Ram R1,3, Raanani P1,2, Bairey O1,2, Robak T4, Gafter-Gvili A1,5, Shpilberg O1,6. Leuk Lymphoma. 2016 Mar 16:1-11. [Epub ahead of print]
Randomized clinical trials that compared chlorambucil to different regimens, for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not support an overall survival (OS) benefit. To assess the efficacy and safety of chlorambucil as frontline treatment, we conducted a systematic review and meta-analysis of randomized controlled trials. OS was the primary outcome. Meta-analysis of 18 trials that compared purine analogs, alkylators, alemtuzumab and ibrutinib to chlorambucil demonstrated no OS benefit for therapy without chlorambucil over chlorambucil (pooled HR 0.99, 95% CI 0.91-1.08; 4133 patients). PFS was longer with purine analogs compared with chlorambucil with an increased risk of infection. The risk of secondary malignancies was not increased with chlorambucil. In conclusion, our study showed that chlorambucil is an acceptable chemotherapy backbone for unfit patients with CLL. Purine analogs should be preferred in fit younger patients because of longer PFS.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 19685-09-7 (S)-10-Hydroxycamptothecin

(S)-10-Hydroxycamptothecin
(CAS: 19685-09-7)

10-Hydroxycamptothecin inhibits the growth of BT-20 and MDA-231 cell with IC50 of 34.3 nM and 7.27 nM, respectively, more potently than camptothecin (CPT) with ...

CAS 874758-58-4 Ecteinascidin-Analog-1

Ecteinascidin-Analog-1
(CAS: 874758-58-4)

Ecteinascidin-Analog-1 is a useful intermediate for chemical sythesis of Ecteinascidin analogues. It is a family of tetrahydroisoquinoline alkaloids with wide r...

CAS 82248-59-7 Atomoxetine HCl

Atomoxetine HCl
(CAS: 82248-59-7)

Atomoxetine is a norepinephrine reuptake inhibitor approved for the treatment of attention deficit hyperactivity disorder (ADHD).

Vadadustat
(CAS: 1000025-07-9)

Vadadustat is a potent Hypoxia-inducible factor-proline dioxygenase inhibitor, which leads to stabilization and increased levels of HIFα. It is used for the tre...

CAS 4382-63-2 PFK15

PFK15
(CAS: 4382-63-2)

PFK15 is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM.

CAS 6873-09-2 Epiberberine

Epiberberine
(CAS: 6873-09-2)

Epiberberine, a natural bioactive alkaloid, has anti-adipogenic effect and is found to have potential effect in blocking cox-2 to get a chemopreventive property...

Lotilaner
(CAS: 1369852-71-0)

Lotilaner is an insecticide and veterinary drug.

CAS 135-16-0 L-Tetrahydrofolic Acid

L-Tetrahydrofolic Acid
(CAS: 135-16-0)

Tetrahydrofolic acid is a folic acid derivative. It is a cofactor in many bio-reactions, especially in the metabolism of amino acids and nucleic acids.

CAS 123-82-0 2-Aminoheptane

2-Aminoheptane
(CAS: 123-82-0)

2-Aminoheptane, a fatty Amine compound, is commonly used in proteomics research and could also be used to product some A3 adenosine receptor antagonists.

CAS 83-63-6 Diacetazotol

Diacetazotol
(CAS: 83-63-6)

Diacetazotol, also referred to Pellidol, inhibits dioxin-induced ethoxyresorufin-O-deethylase (EROD) activity (IC50= 75±4 nM) and has been used in ointment or d...

CAS 882268-69-1 HIF-2a Translation Inhibitor 76

HIF-2a Translation Inhibitor 76
(CAS: 882268-69-1)

A cell-permeable HIF-2a translation inhibitor (IC50 value 5 µM). It inhibits HIF-2a translation via enhancing the binding of IRP1 (Iron-Regulatory Protein 1) to...

CAS 103404-75-7 D-Luciferin sodium salt

D-Luciferin sodium salt
(CAS: 103404-75-7)

Sodium salt form of D-Luciferin, derived from the luciferase gene of photinus pyralis, is commonly used as a reporter gene for studying transcriptional regulati...

CAS 468741-42-6 BMS-554417

BMS-554417
(CAS: 468741-42-6)

BMS-554417 is a novel inhibitor of IGF-IR, which inhibits IGF-IR and insulin receptor kinase activity and proliferation in vitro, with the IC50 for proliferatio...

CAS 541-46-8 Isovaleramide

Isovaleramide
(CAS: 541-46-8)

Isovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.

CAS 22910-60-7 Ginkgolic Acid

Ginkgolic Acid
(CAS: 22910-60-7)

Ginkgolic Acid is a natural compound with suspected cytotoxic, allergenic, mutagenic and carcinogenic properties.

CAS 1799753-63-1 BAY-876

BAY-876
(CAS: 1799753-63-1)

BAY-876 is a potent and selective GLUT1 inhibitor (IC50 = 2 nM) with good stability in vitro and high bioavailability in vivo. BAY-876 can be used as an antican...

CAS 191089-60-8 K-7174 dihydrochloride

K-7174 dihydrochloride
(CAS: 191089-60-8)

K-7174, one of proteasome inhibitory homopiperazine derivatives, exhibits a therapeutic effect, which is stronger when administered orally than intravenously, w...

CAS 961-07-9 2(acute)-Deoxyguanosine

2(acute)-Deoxyguanosine
(CAS: 961-07-9)

2(acute)-Deoxyguanosine is composed of the purine nucleoside guanine linked by its N9 nitrogen to the C1 carbon of deoxyribose. It is a purine nucleoside that u...

CAS 56124-62-0 Valrubicin

Valrubicin
(CAS: 56124-62-0)

Valrubicin (AD-32) is a chemotherapy drug used to treat bladder cancer. It is a semisynthetic analog of the anthracycline doxorubicin, and is administered by in...

CAS 401904-75-4 Carotegrast

Carotegrast
(CAS: 401904-75-4)

Carotegrast is an anti-inflammatory agent as a Integrin alpha4 inhibitor.

Chemical Structure

CAS 305-03-3 Chloroambucil

Quick Inquiry

Verification code

Featured Items